The TNF-Alpha-238 polymorphism and cancer risk: A meta-analysis

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Zhou, Ping ^a   Lv, Guo Qiang ^a   Wang, Jian Zhong ^a   Li, Cheng Wan ^a   Du, Liang Feng ^a   Zhang, Chun ^a   Li, Jian Ping ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; GUANINE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ASIAN; CANCER PATIENT; CANCER RISK; CAUCASIAN; CONTROLLED STUDY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; META ANALYSIS (TOPIC); RISK ASSESSMENT; VALIDITY; BIOLOGICAL MODEL; CONFIDENCE INTERVAL; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; NEOPLASM; PUBLISHING; RISK; RISK FACTOR;

CONFIDENCE INTERVALS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MODELS, GENETIC; NEOPLASMS; ODDS RATIO; POLYMORPHISM, GENETIC; PUBLICATION BIAS; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79960470168     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022092     Document Type: Article

References (44)

1. Anderson GM, Nakada MT, DeWitte M, (2004) Tumor necrosis factor-alpha in the pathogenesis and treatment of cancer. Curr Opin Pharmacol 4: 314-320.
2. Wang SS, Purdue MP, Cerhan JR, Zheng T, Menashe I, et al. (2009) Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk. PLoS One 4: e5360.
3. Huizinga TW, Westendorp RG, Bollen EL, Keijsers V, Brinkman BM, et al. (1997) TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. J Neuroimmunol 72: 149-153.
4. Hellmig S, Fischbach W, Goebeler-Kolve ME, Folsch UR, Hampe J, et al. (2005) A functional promotor polymorphism of TNF-alpha is associated with primary gastric B-Cell lymphoma. Am J Gastroenterol 100: 2644-2649.
5. Lindholm E, Bakhtadze E, Cilio C, Agardh E, Groop L, et al. (2008) Association between LTA, TNF and AGER polymorphisms and late diabetic complications. PLoS One 3: e2546.
6. Shen C, Sun H, Sun D, Xu L, Zhang X, et al. (2010) Polymorphisms of tumor necrosis factor-alpha and breast cancer risk: a meta-analysis. Breast Cancer Res Treat.
7. Lu PH, Tang Y, Li C, Shen W, Ji L, et al. (2010) [Meta-analysis of association of tumor necrosis factor alpha-308 gene promoter polymorphism with gastric cancer]. Zhonghua Yu Fang Yi Xue Za Zhi 44: 209-214.
8. Yang Y, Luo C, Feng R, Bi S, (2010) The TNF-alpha, IL-1B and IL-10 polymorphisms and risk for hepatocellular carcinoma: a meta-analysis. J Cancer Res Clin Oncol.
9. Jang WH, Yang YI, Yea SS, Lee YJ, Chun JH, et al. (2001) The-238 tumor necrosis factor-alpha promoter polymorphism is associated with decreased susceptibility to cancers. Cancer Lett 166: 41-46.
10. Yea SS, Yang YI, Jang WH, Lee YJ, Bae HS, et al. (2001) Association between TNF-alpha promoter polymorphism and Helicobacter pylori cagA subtype infection. J Clin Pathol 54: 703-706.
11. Zambon CF, Basso D, Navaglia F, Belluco C, Falda A, et al. (2005) Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine 29: 141-152.
12. Yang JJ, Ko KP, Cho LY, Shin A, Gwack J, et al. (2009) The role of TNF genetic variants and the interaction with cigarette smoking for gastric cancer risk: a nested case-control study. BMC Cancer 9: 238.
13. Wu MS, Huang SP, Chang YT, Shun CT, Chang MC, et al. (2002) Tumor necrosis factor-alpha and interleukin-10 promoter polymorphisms in Epstein-Barr virus-associated gastric carcinoma. J Infect Dis 185: 106-109.
14. Wu MS, Chen LT, Shun CT, Huang SP, Chiu HM, et al. (2004) Promoter polymorphisms of tumor necrosis factor-alpha are associated with risk of gastric mucosa-associated lymphoid tissue lymphoma. Int J Cancer 110: 695-700.
15. Whiteman DC, Parmar P, Fahey P, Moore SP, Stark M, et al. (2010) Association of Helicobacter pylori infection with reduced risk for esophageal cancer is independent of environmental and genetic modifiers. Gastroenterology 139: 73-83 quiz e11-72.
16. Gupta R, Sharma SC, Das SN, (2008) Association of TNF-alpha and TNFR1 promoters and 3′ UTR region of TNFR2 gene polymorphisms with genetic susceptibility to tobacco-related oral carcinoma in Asian Indians. Oral Oncol 44: 455-463.
17. Gostout BS, Poland GA, Calhoun ES, Sohni YR, Giuntoli RL, 2nd, et al. (2003) TAP1, TAP2, and HLA-DR2 alleles are predictors of cervical cancer risk. Gynecol Oncol 88: 326-332.
18. Garcia-Gonzalez MA, Savelkoul PH, Benito R, Santolaria S, Crusius JB, et al. (2005) No allelic variant associations of the IL-1 and TNF gene polymorphisms in the susceptibility to duodenal ulcer disease. Int J Immunogenet 32: 299-306.
19. Flego V, Radojcic Badovinac A, Bulat-Kardum L, Matanic D, Crnic-Martinovic M, et al. (2009) Primary lung cancer and TNF-alpha gene polymorphisms: a case-control study in a Croatian population. Med Sci Monit 15: CR361-365.
20. Berkovic M, Cacev T, Zjacic-Rotkvic V, Kapitanovic S, (2006) TNF-alpha promoter single nucleotide polymorphisms in gastroenteropancreatic neuroendocrine tumors. Neuroendocrinology 84: 346-352.
21. Azmy IA, Balasubramanian SP, Wilson AG, Stephenson TJ, Cox A, et al. (2004) Role of tumour necrosis factor gene polymorphisms (-308 and-238) in breast cancer susceptibility and severity. Breast Cancer Res 6: R395-400.
22. Shih CM, Lee YL, Chiou HL, Chen W, Chang GC, et al. (2006) Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer. Lung Cancer 52: 15-20.
23. Oh BR, Sasaki M, Perinchery G, Ryu SB, Park YI, et al. (2000) Frequent genotype changes at-308, and 488 regions of the tumor necrosis factor-alpha (TNF-alpha) gene in patients with prostate cancer. J Urol 163: 1584-1587.
24. Neben K, Mytilineos J, Moehler TM, Preiss A, Kraemer A, et al. (2002) Polymorphisms of the tumor necrosis factor-alpha gene promoter predict for outcome after thalidomide therapy in relapsed and refractory multiple myeloma. Blood 100: 2263-2265.
25. Nakajima K, Sasaki M, Nojima D, Oh BR, Ishii N, et al. (2001) Tumor necrosis factor-alpha gene mutations and genotype changes in renal cell carcinoma. J Urol 165: 612-615.
26. Morgan GJ, Adamson PJ, Mensah FK, Spink CF, Law GR, et al. (2005) Haplotypes in the tumour necrosis factor region and myeloma. Br J Haematol 129: 358-365.
27. Madani S, Noorinayer B, Madani H, Sadrolhefazi B, Molanayee S, et al. (2008) No association between TNF-alpha-238 polymorphism and colorectal cancer in Iranian patients. Acta Oncol 47: 473-474.
28. Liu CJ, Wong YK, Chang KW, Chang HC, Liu HF, et al. (2005) Tumor necrosis factor-alpha promoter polymorphism is associated with susceptibility to oral squamous cell carcinoma. J Oral Pathol Med 34: 608-612.
29. Lee SG, Kim B, Yook JH, Oh ST, Lee I, et al. (2004) TNF/LTA polymorphisms and risk for gastric cancer/duodenal ulcer in the Korean population. Cytokine 28: 75-82.
30. Kummee P, Tangkijvanich P, Poovorawan Y, Hirankarn N, (2007) Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population. J Viral Hepat 14: 841-848.
31. Kohaar I, Tiwari P, Kumar R, Nasare V, Thakur N, et al. (2009) Association of single nucleotide polymorphisms (SNPs) in TNF-LTA locus with breast cancer risk in Indian population. Breast Cancer Res Treat 114: 347-355.
32. Kamangar F, Abnet CC, Hutchinson AA, Newschaffer CJ, Helzlsouer K, et al. (2006) Polymorphisms in inflammation-related genes and risk of gastric cancer (Finland). Cancer Causes Control 17: 117-125.
33. Heneghan MA, Johnson PJ, Clare M, Ho S, Harrison PM, et al. (2003) Frequency and nature of cytokine gene polymorphisms in hepatocellular carcinoma in Hong Kong Chinese. Int J Gastrointest Cancer 34: 19-26.
34. Glas J, Torok HP, Schneider A, Brunnler G, Kopp R, et al. (2004) Allele 2 of the interleukin-1 receptor antagonist gene is associated with early gastric cancer. J Clin Oncol 22: 4746-4752.
35. Gaudet MM, Milne RL, Cox A, Camp NJ, Goode EL, et al. (2009) Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev 18: 1610-1616.
36. Danforth KN, Rodriguez C, Hayes RB, Sakoda LC, Huang WY, et al. (2008) TNF polymorphisms and prostate cancer risk. Prostate 68: 400-407.
37. Wang Y, Kato N, Hoshida Y, Yoshida H, Taniguchi H, et al. (2003) Interleukin-1beta gene polymorphisms associated with hepatocellular carcinoma in hepatitis C virus infection. Hepatology 37: 65-71.
38. Lu W, Pan K, Zhang L, Lin D, Miao X, et al. (2005) Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor {alpha} and risk of gastric cancer in a Chinese population. Carcinogenesis 26: 631-636.
39. Kohaar I, Thakur N, Salhan S, Batra S, Singh V, et al. (2007) TNFalpha-308G/A polymorphism as a risk factor for HPV associated cervical cancer in Indian population. Cell Oncol 29: 249-256.
40. Jung KW, Ha E, Yu GI, Kim SJ, Chung WJ, et al. (2009) TNFalpha promoter polymorphism is a risk factor for susceptibility in hepatocellular carcinoma in Korean population. Clin Chim Acta 407: 16-19.
41. Howell WM, Turner SJ, Collins A, Bateman AC, Theaker JM, (2002) Influence of TNFalpha and LTalpha single nucleotide polymorphisms on susceptibility to and prognosis in cutaneous malignant melanoma in the British population. Eur J Immunogenet 29: 17-23.
42. Zhu W, Wei BB, Shan X, Liu P, (2010)-765G>C and 8473T>C polymorphisms of COX-2 and cancer risk: a meta-analysis based on 33 case-control studies. Mol Biol Rep 37: 277-288.
43. Xu B, Niu XB, Wang ZD, Cheng W, Tong N, et al. (2010) IL-6-174G>C polymorphism and cancer risk: a meta-analysis involving 29,377 cases and 37,739 controls. Mol Biol Rep.
44. Elahi MM, Asotra K, Matata BM, Mastana SS, (2009) Tumour Necrosis Factor Alpha-308 Gene Locus Promoter Polymorphism: An Analysis of Association with Health and Disease. Biochim Biophys Acta.